Insider Buying: Anagenics (ASX:AN1) Insider Purchases A$19,950.00 in Stock

Anagenics Limited (ASX:AN1) insider Alexander (Sandy) Beard purchased 2,850,000 shares of the firm’s stock in a transaction dated Thursday, February 26th. The stock was acquired at an average cost of A$0.01 per share, with a total value of A$19,950.00.

Anagenics Stock Performance

The company has a current ratio of 1.10, a quick ratio of 1.15 and a debt-to-equity ratio of 43.43. The company has a market capitalization of $3.26 million, a price-to-earnings ratio of -6.19 and a beta of -1.03.

About Anagenics

Anagenics Limited operates as a health and beauty tech company in Australia, New Zealand, and internationally. It develops and sells FGF5 inhibitor formulations; over-the-counter (OTC), cosmetic antiaging, and longevity targeting products; and imports and distributes international and local skin care and wellbeing products under the Thalgo, Hydro Peptide, Comfort Zone, Priori, and Inika Organic brand names. The company also develops, manufactures, and markets beauty and wellness brands comprising Uspa and evolis.